PROGESTERONE TREATMENT TO PREVENT PRETERM LABOR

Preterm birth is called births that occur before 37 weeks of gestation. Preterm labor threat is the onset of contractions before 37 weeks of gestation. Approximately 10 percent of all births occur in the form of preterm birth. Premature births are responsible for a very important part of the deaths in the neonatal period. For this reason, new protocols and new drugs are constantly being researched to prevent preterm births and to manage their treatment and complications in the best way possible. The research and recommendations made in recent years on the effectiveness of progesterone drugs in the prevention of preterm births are summarized below.
There is no change in the level of progesterone in maternal blood in the weeks before birth, but functional progesterone withdrawal occurs immediately before birth (in preterm or term deliveries). For this reason, progesterone is thought to be responsible for uterine relaxation during the weeks of gestation and the onset of delivery afterwards.
Use of progesterone to prevent preterm labor:
- In patients with no previous history of preterm labor and unknown cervical length, progesterone is not recommended to prevent preterm labor. There is not enough evidence to recommend it.
- (Routine cervical length assessment is not recommended in the low-risk patient group during pregnancy.)
- Progesterone treatment is recommended for the purpose of preventing preterm delivery in patients with no previous preterm labor history and cervical length measured below 20 mm.
- In order to prevent preterm delivery in pregnancies with a preterm delivery history, 250 mg hydroxyprogesterone (intramuscular) is recommended once a week between 20-37 weeks of gestation.
- The use of progesterone is not recommended to prevent preterm labor in twin-triplet pregnancies, its benefit has not been proven.
- Progesterone is not recommended for PPROM patients in order to prevent preterm labor.


Facebook Comments

Popular Posts